- Home
- Publications
- Publication Search
- Publication Details
Title
The role of complete response in multiple myeloma
Authors
Keywords
-
Journal
BLOOD
Volume 114, Issue 15, Pages 3139-3146
Publisher
American Society of Hematology
Online
2009-07-29
DOI
10.1182/blood-2009-03-201053
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Response level and survival after conventional chemotherapy for multiple myeloma: a Finnish Leukaemia Group study
- (2010) Tiina M. Oivanen et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- A monoclonal gammopathy precedes multiple myeloma in most patients
- (2009) B. M. Weiss et al. BLOOD
- Consolidation Therapy With Low-Dose Thalidomide and Prednisolone Prolongs the Survival of Multiple Myeloma Patients Undergoing a Single Autologous Stem-Cell Transplantation Procedure
- (2009) Andrew Spencer et al. JOURNAL OF CLINICAL ONCOLOGY
- Thalidomide-dexamethasone compared with melphalan-prednisolone in elderly patients with multiple myeloma
- (2008) H. Ludwig et al. BLOOD
- Thalidomide arm of Total Therapy 2 improves complete remission duration and survival in myeloma patients with metaphase cytogenetic abnormalities
- (2008) B. Barlogie et al. BLOOD
- Rituximab combined with chemotherapy and interferon in follicular lymphoma patients: results of the GELA-GOELAMS FL2000 study
- (2008) G. Salles et al. BLOOD
- Oral melphalan, prednisone, and thalidomide in elderly patients with multiple myeloma: updated results of a randomized controlled trial
- (2008) A. Palumbo et al. BLOOD
- Multiparameter flow cytometric remission is the most relevant prognostic factor for multiple myeloma patients who undergo autologous stem cell transplantation
- (2008) B. Paiva et al. BLOOD
- The relationship between quality of response and clinical benefit for patients treated on the bortezomib arm of the international, randomized, phase 3 APEX trial in relapsed multiple myeloma
- (2008) Ruben Niesvizky et al. BRITISH JOURNAL OF HAEMATOLOGY
- Sustained complete remissions in multiple myeloma linked to bortezomib in total therapy 3: comparison with total therapy 2
- (2008) Mauricio Pineda-Roman et al. BRITISH JOURNAL OF HAEMATOLOGY
- High-dose melphalan-based autotransplants for multiple myeloma
- (2008) Mauricio Pineda-Roman et al. CANCER
- Complete remission sustained 3 years from treatment initiation is a powerful surrogate for extended survival in multiple myeloma
- (2008) Bart Barlogie et al. CANCER
- Thalidomide in induction treatment increases the very good partial response rate before and after high-dose therapy in previously untreated multiple myeloma
- (2008) H. M. Lokhorst et al. HAEMATOLOGICA
- Suppression of abnormal karyotype predicts superior survival in multiple myeloma
- (2008) V Arzoumanian et al. LEUKEMIA
- Making progress in treating multiple myeloma with total therapies: issue of complete remission and more
- (2008) B Barlogie et al. LEUKEMIA
- A kinder, gentler way: control of the proliferative tumor compartment, not cosmetic complete response, should be the goal of myeloma therapy
- (2008) P L Bergsagel LEUKEMIA
- International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders
- (2008) A Dispenzieri et al. LEUKEMIA
- Bortezomib plus Melphalan and Prednisone for Initial Treatment of Multiple Myeloma
- (2008) Jesús F. San Miguel et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search